Immix Biopharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	15.95	17.68	17.51	13.44	17.64	0.39
Cash & Short-Term Investments	15.95	17.68	17.51	13.44	17.64	0.39
Cash Growth	-19.01%	0.98%	30.31%	-23.85%	4411.66%	-46.72%
Other Receivables	-	1.97	1.17	0.26	0.03	0.13
Total Trade Receivables	-	1.97	1.17	0.26	0.03	0.13
Other Current Assets	0.64	0.54	1.11	1.21	0.52	0.01
Total Current Assets	16.58	20.2	19.79	14.9	18.19	0.53
Net Property, Plant & Equipment	2.47	2.73	0.05	0	0.01	0.01
Other Long-Term Assets	0.02	0.02	0.09	0.01	-	-
Total Assets	20.08	22.95	19.93	14.91	18.19	0.54
Accounts Payable	10.71	8.62	3.72	1.27	0.14	0.25
Accrued Expenses	-	-	-	-	0.01	0.34
Short-Term Debt	-	-	-	-	0.05	0.05
Current Portion of Long-Term Debt	-	-	-	-	-	4.05
Current Portion of Leases	0.14	0.07	-	-	-	-
Other Current Liabilities	-	-	-	-	-	0.58
Total Current Liabilities	10.85	8.69	3.72	1.27	0.2	5.27
Long-Term Leases	0.97	1.01	-	-	-	-
Other Long-Term Liabilities	-	-	-	0.48	-	-
Total Long-Term Liabilities	0.97	1.01	-	0.48	-	-
Total Liabilities	11.82	9.7	3.72	1.75	0.2	5.27
Common Stock	0	0	0	0	0	0
Treasury Stock	-0.1	-0.1	-0.1	-0.1	-	-
Additional Paid-in Capital	102.07	88.37	69.78	51.16	47.62	0.51
Accumulated Other Comprehensive Income	0.06	-0	0.13	0.09	0.13	0.13
Retained Earnings	-93.78	-75.02	-53.41	-37.99	-29.76	-5.37
Total Common Shareholders' Equity	8.26	13.25	16.41	13.16	17.99	-4.73
Minority Interest	-	-	-0.2	-	-	-
Shareholders' Equity	8.26	13.25	16.2	13.16	17.99	-4.73
Total Liabilities & Equity	20.08	22.95	19.93	14.91	18.19	0.54
Total Debt	1.11	1.07	0	0	0.05	4.1
Net Cash (Debt)	14.84	16.61	17.51	13.44	17.59	-3.71
Net Cash Growth	-10.63%	-5.16%	30.31%	-23.63%	-	-
Net Cash Per Share	0.49	0.59	1.01	0.97	4.79	-1.10
Book Value	8.26	13.25	16.41	13.16	17.99	-4.73
Book Value Per Share	0.27	0.47	0.95	0.95	4.90	-1.40
Tangible Book Value	8.26	13.25	16.41	13.16	17.99	-4.73
Tangible Book Value Per Share	0.27	0.47	0.95	0.95	4.90	-1.40

Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q